Newly Proposed Dose of Daclatasvir to Prevent Lethal SARS-CoV-2 Infection in Human Transgenic ACE-2 Mice
Sign Up to like & getrecommendations! Published in 2024 at "Viruses"
DOI: 10.3390/v16121856
Abstract: Coronavirus disease 2019 (COVID-19) still causes death in elderly and immunocompromised individuals, for whom the sustainability of the vaccine response may be limited. Antiviral treatments, such as remdesivir or molnupiravir, have demonstrated limited clinical efficacy.… read more here.
Keywords: sars cov; mice; dose daclatasvir; daclatasvir ... See more keywords